This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3fq9
From Proteopedia
| Line 1: | Line 1: | ||
{{Seed}} | {{Seed}} | ||
| - | [[Image:3fq9. | + | [[Image:3fq9.png|left|200px]] |
<!-- | <!-- | ||
| Line 12: | Line 12: | ||
===Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications=== | ===Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications=== | ||
| + | |||
| + | <!-- | ||
| + | The line below this paragraph, {{ABSTRACT_PUBMED_19773552}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 19773552 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_19773552}} | ||
==About this Structure== | ==About this Structure== | ||
3FQ9 is a 4 chains structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FQ9 OCA]. | 3FQ9 is a 4 chains structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FQ9 OCA]. | ||
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:19773552</ref><references group="xtra"/> | ||
[[Category: Katsoyannis, P.]] | [[Category: Katsoyannis, P.]] | ||
[[Category: Phillips, N.]] | [[Category: Phillips, N.]] | ||
| Line 37: | Line 46: | ||
[[Category: Therapeutic implication]] | [[Category: Therapeutic implication]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Nov 25 09:31:43 2009'' |
Revision as of 07:31, 25 November 2009
Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications
Template:ABSTRACT PUBMED 19773552
About this Structure
3FQ9 is a 4 chains structure. Full crystallographic information is available from OCA.
Reference
- Zhao M, Wan ZL, Whittaker L, Xu B, Phillips NB, Katsoyannis PG, Ismail-Beigi F, Whittaker J, Weiss MA. Design of an insulin analog with enhanced receptor binding selectivity: rationale, structure, and therapeutic implications. J Biol Chem. 2009 Nov 13;284(46):32178-87. Epub 2009 Sep 22. PMID:19773552 doi:10.1074/jbc.M109.028399
Page seeded by OCA on Wed Nov 25 09:31:43 2009
Categories: Katsoyannis, P. | Phillips, N. | Wan, Z L. | Weiss, M A. | Whittaker, J. | Whittaker, L. | Xu, B. | Zhao, M. | Carbohydrate metabolism | Cleavage on pair of basic residue | Diabetes mellitus | Disease mutation | Glucose metabolism | Hormone | Insulin design | Pharmaceutical | Rational | Receptor-binding | Secreted | Structure | Therapeutic implication
